Cancer Research UK is committed to helping research scientists bring their work into the clinic and give each promising new therapy a chance of becoming the medicine of tomorrow.
Our Drug Development Office has specialised in early phase oncology trials for almost 30 years. We have an impressive range of capabilities including the ability to manufacture and formulate small molecules and biological therapies.
From pharmaceutical companies to academic researchers and their groups, Cancer Research UK's Drug Development Office can help maximise the potential of oncology projects.
Many researchers depend on Cancer Research UK to take their discoveries in the lab and turn them into effective treatments against cancer.